Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL

Clinical trial NCT01217749 · COMPLETED

Trial details

NCT number: NCT01217749
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Prolymphocyctic Leukemia Richter's Transformation

Start date: 2010-12-01
Primary completion: 2013-06-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.